{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:58:23Z","timestamp":1784883503172,"version":"3.55.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1S","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Obesity is a well-known risk factor for nonalcoholic fatty liver disease (NAFLD), and weight reduction is primarily recommended for managing the disease. However, some NAFLD patients have a normal weight (lean NAFLD), and whether weight reduction is also recommendable for lean NAFLD patients remains unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a longitudinal study of 16\u2009738 adults (average age, 50.5\u2009years; lean NAFLD, 2383 participants) with NAFLD at baseline who underwent repeated health check-up examinations, including bodyweight measurements and abdominal ultrasonography from January 2003 through December 2013.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>During 68\u2009389 person-years of follow-up (median follow-up of 3.00\u2009years), 5819 patients had a fatty liver resolution. Compared with participants who had no weight reduction or increased weight, the fully adjusted hazard ratios for fatty liver resolution in participants with 0\u20134.9, 5\u20139.9 and 10% or more weight reduction were 1.67 [95% confidence interval (CI), 1.57\u20131.77], 3.36 (95% CI, 3.09\u20133.65) and 5.50 (95% CI, 4.83\u20136.27), respectively. The association between weight reduction and the fatty liver resolution was stronger in overweight\/obese NAFLD participants but was also evident in lean NAFLD participants in a dose-dependent manner. In spline regression models, the association between weight change and the fatty liver resolution was linear among participants with normal weight.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>There was a dose-dependent association between weight reduction and fatty liver resolution in both lean and overweight\/obese NAFLD patients. This finding suggests weight reduction as a primary recommendation for lean NAFLD patients as in overweight\/obese NAFLD patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/meg.0000000000002158","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T19:28:56Z","timestamp":1618860536000},"page":"e529-e534","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":34,"title":["Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease"],"prefix":"10.1097","volume":"33","author":[{"given":"Dong Hyun","family":"Sinn","sequence":"first","affiliation":[{"name":"Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danbee","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Clinical Research Design and Evaluation, SAIHST"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jin","family":"Cho","sequence":"additional","affiliation":[{"name":"Center for Health Promotion, Samsung Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Woon","family":"Paik","sequence":"additional","affiliation":[{"name":"Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliseo","family":"Guallar","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology, Samsung Medical Center, Seoul, South Korea"},{"name":"Departments of Epidemiology and Medicine and Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhee","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Clinical Research Design and Evaluation, SAIHST"},{"name":"Center for Clinical Epidemiology, Samsung Medical Center, Seoul, South Korea"},{"name":"Departments of Epidemiology and Medicine and Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geum-Youn","family":"Gwak","sequence":"additional","affiliation":[{"name":"Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"key":"R1-20240821","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3350\/cmh.2013.19.4.325","article-title":"KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.","volume":"19","year":"2013","journal-title":"Clin Mol Hepatol"},{"key":"R2-20240821","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia.","volume":"67","author":"Fan","year":"2017","journal-title":"J Hepatol"},{"key":"R3-20240821","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R5-20240821","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cld.2013.09.018","article-title":"Obesity-associated nonalcoholic fatty liver disease.","volume":"18","author":"Yilmaz","year":"2014","journal-title":"Clin Liver Dis"},{"key":"R6-20240821","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3803\/EnM.2014.29.4.405","article-title":"2014 clinical practice guidelines for overweight and obesity in Korea.","volume":"29","author":"Kim","year":"2014","journal-title":"Endocrinol Metab (Seoul)"},{"key":"R7-20240821","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1210\/jc.2015-3444","article-title":"Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies.","volume":"101","author":"Loomis","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-20240821","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00535-014-0948-9","article-title":"Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011-2012.","volume":"50","author":"Nishioji","year":"2015","journal-title":"J Gastroenterol"},{"key":"R9-20240821","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"R10-20240821","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1038\/s41598-017-05040-6","article-title":"Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice.","volume":"7","author":"Tu","year":"2017","journal-title":"Sci Rep"},{"key":"R11-20240821","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/apt.14112","article-title":"Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients.","volume":"46","author":"Sookoian","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R12-20240821","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ajg.2011.400","article-title":"Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults.","volume":"107","author":"Sinn","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R13-20240821","doi-asserted-by":"crossref","first-page":"e0192663","DOI":"10.1371\/journal.pone.0192663","article-title":"Insulin resistance in lean and overweight non-diabetic Caucasian adults: study of its relationship with liver triglyceride content, waist circumference and BMI.","volume":"13","author":"Gonzalez-Cantero","year":"2018","journal-title":"PLoS One"},{"key":"R14-20240821","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/apt.14401","article-title":"Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.","volume":"47","author":"Sookoian","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"R15-20240821","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s00535-019-01628-z","article-title":"Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis.","volume":"55","author":"Kim","year":"2020","journal-title":"J Gastroenterol"},{"key":"R16-20240821","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00535-019-01650-1","article-title":"Is metabolic syndrome responsible for the progression from NAFLD to NASH in non-obese patients?","volume":"55","author":"Kawaguchi","year":"2020","journal-title":"J Gastroenterol"},{"key":"R17-20240821","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"R18-20240821","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3350\/cmh.2016.0049","article-title":"Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment.","volume":"22","author":"Oh","year":"2016","journal-title":"Clin Mol Hepatol"},{"key":"R19-20240821","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"key":"R20-20240821","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis.","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterol"},{"key":"R21-20240821","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2018.08.011","article-title":"Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.","volume":"69","author":"Wong","year":"2018","journal-title":"J Hepatol"},{"key":"R22-20240821","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.292.6512.13","article-title":"Ultrasound scanning in the detection of hepatic fibrosis and steatosis.","volume":"292","author":"Saverymuttu","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R23-20240821","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"R24-20240821","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R25-20240821","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"R26-20240821","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ajg.2016.527","article-title":"Editorial: \u201cLean\u201d NAFLD: metabolic obesity with normal BMI\u2026 Is it in the genes?","volume":"112","author":"Argo","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R27-20240821","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1001\/archinte.164.19.2169","article-title":"Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.","volume":"164","author":"Kim","year":"2004","journal-title":"Arch Intern Med"},{"key":"R28-20240821","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/j.1440-1746.2012.07222.x","article-title":"Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese.","volume":"27","author":"Liu","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"R29-20240821","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ajg.2016.318","article-title":"Clinical and metabolic characterization of lean caucasian subjects with non-alcoholic fatty liver.","volume":"112","author":"Feldman","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R30-20240821","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2016.0109","article-title":"Genetic predisposition in nonalcoholic fatty liver disease.","volume":"23","author":"Sookoian","year":"2017","journal-title":"Clin Mol Hepatol"},{"issue":"Suppl 1","key":"R31-20240821","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000447275","article-title":"Pathophysiology of nonalcoholic fatty liver disease: lifestyle-gut-gene interaction.","volume":"34","author":"Mazzotti","year":"2016","journal-title":"Dig Dis"},{"key":"R32-20240821","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5009\/gnl14444","article-title":"Prevalence and factors associated with nonalcoholic fatty liver disease in a nonobese Korean population.","volume":"10","author":"Cho","year":"2016","journal-title":"Gut Liver"},{"key":"R33-20240821","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1440-1746.2004.03362.x","article-title":"Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men.","volume":"19","author":"Park","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"R34-20240821","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/jgh.12861","article-title":"Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals.","volume":"30","author":"Kimura","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"R35-20240821","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/gut.2008.161885","article-title":"Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men.","volume":"58","author":"Chang","year":"2009","journal-title":"Gut"},{"key":"R36-20240821","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2337\/diabetes.54.3.603","article-title":"Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.","volume":"54","author":"Petersen","year":"2005","journal-title":"Diabetes"},{"key":"R37-20240821","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis.","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"key":"R38-20240821","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/TP.0b013e31828d1588","article-title":"Steatosis among living liver donors without evidence of fatty liver on ultrasonography: potential implications for preoperative liver biopsy.","volume":"95","author":"Ahn","year":"2013","journal-title":"Transplantation"},{"key":"R39-20240821","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3350\/cmh.2017.0042","article-title":"Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification.","volume":"23","author":"Lee","year":"2017","journal-title":"Clin Mol Hepatol"},{"key":"R40-20240821","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3945\/an.116.014506","article-title":"Preserving healthy muscle during weight loss.","volume":"8","author":"Cava","year":"2017","journal-title":"Adv Nutr"},{"key":"R41-20240821","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s12072-019-09996-7","article-title":"Sarcopenia and fatty liver disease.","volume":"13","author":"Kim","year":"2019","journal-title":"Hepatol Int"}],"container-title":["European Journal of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000002158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T22:05:42Z","timestamp":1724364342000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000002158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":40,"journal-issue":{"issue":"1S","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000002158","relation":{},"ISSN":["0954-691X"],"issn-type":[{"value":"0954-691X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,16]]}}}